Lithium Therapy

Atlanta, Georgia, August 20, 2026 Alzamend Neuro, Inc. has announced that data from its Phase 1/2A clinical trial of...

ATLANTA, United States, April 7, 2026 Alzamend Neuro, Inc. announced encouraging pharmacodynamic data from its Phase II clinical trial...